Stay updated with breaking news from Graybug Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocular Drug Delivery Technology Market to Witness Revolutionary Growth by 2026 | Alimera Sciences, EyeGate Pharma, Graybug Vision
MINNEAPOLIS--(BUSINESS WIRE)--Jul 15, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Companyâs Board of Directors. Amy Burroughs, President and CEO of Cleave Therapeutics, brings over 20 years of experience in business and commercial development, strategy and leadership in the pharmaceutical industry. Dr. Charles Semba, Chief Medical Officer of Eluminex Biosciences, has over 20 years of drug-deve...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock […]
Graybug Vision Inc (NASDAQ: GRAY) has not released any news since it printed its first-quarter 2021 earnings results May 12, but that didn’t stop the ...
/PRNewswire/ -- DelveInsight's 'Age-related Vision Dysfunction Market, Epidemiology and Market Forecast-2030' report presents a holistic picture of the...